Skip to content
OpenCapital
Get started

Fulcrum Therapeutics, Inc. FULC Q1 2026 earnings

Reported April 27, 2026 · Before market open

EPS-$0.25Beat by $0.06
EPS estimate-$0.31

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.21

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.06
Q4 2025-$0.31In lineQ3 2025-$0.31Miss by $0.02Q2 2025-$0.28Beat by $0.01Q1 2025-$0.28Beat by $0.01Q4 2024-$0.31Miss by $0.03

Ask the moment Fulcrum Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fulcrum Therapeutics, Inc. report Q1 2026 earnings?
Fulcrum Therapeutics, Inc. (FULC) reported Q1 2026 earnings on April 27, 2026 before market open.
What were Fulcrum Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Fulcrum Therapeutics, Inc. reported eps of $-0.25 for Q1 2026.
Did Fulcrum Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.31 by $0.06.
How did Fulcrum Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 10.7% from $-0.28.
Where can I find Fulcrum Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-178806) and the 10-Q periodic report (0001193125-26-178814) directly on SEC EDGAR. The filing index links above go to sec.gov.